Pharmacokinetics of mycophenolic acid in living donor liver transplantation

Transplantation Proceedings

Volumn 42, Issue 3, 2010, Pages 846-853

  Shin, M ^a   Moon, J I ^a   Kim, J M ^a   Choi, G S ^a   Kwon, C H ^a   Kim, S J ^a   Joh, J W ^a   Lee, S K ^a   Lee, S T ^a   Jung, H ^a   Lee, S Y ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; TIME;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77955482754     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.004     Document Type: Conference Paper

References (37)

1. The European Mycophenolate Mofetil Co-operative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection Lancet 1 1995 1321
2. M.F. Herbert, N.L. Ascher, and J.R. Lake Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients Transplantation 67 1999 707
3. R. Wiesner, J. Rabkin, and G. Klintmalm A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients Liver Transpl 7 2001 442
4. R.E. Bullingham, A.J. Nicholls, and B.R. Kamm Clinical pharmacokinetics of mycophenolate mofetil Clin Pharmacokinet 34 1998 429
5. E.M. Eugui, and A.C. Allison Immunosuppressive activity of mycophenolate mofetil Ann NY Acad Sci 685 1993 309
6. S.R. Knight, and P.J. Morris Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review Transplantation 85 2008 1675
7. S. Irtan, S. Azougagh, and C. Monchaud Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in pediatric renal recipients Pediatr Nephrol 23 2008 1859
8. E. Schutz, M. Shipkova, and V.W. Armstrong Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil Clin Chem 45 1999 419
9. M. Shipkova, E. Wieland, and E. Schutz The acylglucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes Transplant Proc 33 2001 1080
10. L.M. Shaw, M. Korecka, and D. DeNofrio Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal transplant patients Clin Biochem 34 2001 17
11. M. Mourad, J. Malaise, and D. Chaib Eddour Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil Clin Chem 47 2001 88
12. H.W. Sollinger Mycophenolates in transplantation Clin Transplant 18 2004 485
13. CellCept 2004 Roche Laboratories Inc Nutley, NJ
14. A. Jain, R. Venkataramanan, and I.S. Hamad Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus J Clin Pharmacol 41 2001 268
15. M. Brunet, I. Cirera, and J. Martorell Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil Transplantation 81 2006 541
16. A. Jain, R. Venkataramanan, and T. Kwong Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil Liver Transpl 13 2007 791
17. R.E. Bullingham, A.J. Nicholls, and B.R. Kamm Clinical pharmacokinetics of mycophenolate mofetil Clin Pharmacokinet 34 1998 429
18. R. Kuypers, K. Claes, and P. Evenepoel Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients J Clin Pharmacol 43 2003 866
19. H. Chen, C. Peng, and Z. Yu Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients Clin Pharmacokinet 46 2007 175
20. R. Venkataramanan, and L.W. Shaw Therapeutic monitoring of mycophenolic acid in liver transplant patients Liver Transpl 10 2004 503
21. C. Hao, M. Anwei, and C. Bing Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia Liver Transpl 14 2008 1165
22. K. Zucker, A. Tsaroucha, and L. Olson Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation Ther Drug Monit 21 1999 35
23. C. Hao, C. Erzheng, and M. Anwei Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients Liver Transpl 13 2007 1684
24. T. van Gelder, H.T. Silva, and H. De Fijter A prospective, randomized study comparing fixed dose vs concentration controlled MMF regimens for de novo patients following renal transplantation (the FDCC trial) Transplantation 82 2006 343
25. Y. Le Meur, M. Buchler, and A. Thierry Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patients outcomes after renal transplantation Am J Transplant 7 2007 2496
26. E. Schutz, M. Shipkova, and V.W. Armstrong Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites Transplant Proc 30 1998 1185
27. A. Premaud, A. Rousseau, and Y. Le Meur Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring Ther Drug Monit 26 2004 609
28. M.M. Aw, N.W. Brown, and T. Itsuka Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients Liver Transpl 9 2003 383
29. V. Mardigyan, J. Tchervenkov, and P. Metrakos Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation Clin Ther 27 2005 463
30. M. Cantarovich, J. Fridell, and J. Barkun Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus Transplant Proc 30 1998 1460
31. M.D. Aumente Rubio, and J.M. Arizon del Prado Clinical pharmacokinetics oftacrolimus in heart transplantation: New strategies of monitoring Transplant Proc 35 2003 1988
32. 2 levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients Nephrol Dial Transplant 17 2002 1487
33. J.M. Tredger, N.W. Brown, and J. Adams Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range Liver Transpl 10 2004 492
34. D.R. Kuypers, Y. Vanrenterghem, and J.P. Squifflet Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil Ther Drug Monit 25 2003 609
35. J.M. Tredger, N.W. Brown, and J. Adams Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range Liver Transpl 10 2004 492
36. A. Jain, R. Venkataramanan, and I.S. Hamad Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus J Clin Pharmacol 41 2001 268
37. J. Pisupati, A. Jain, and G. Burckart Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients J Clin Pharmacol 45 2005 34